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Loss of epithelial cell polarity and inflammation are hallmarks of breast cancer development. Although the
association between the disruption of tissue polarity and inflammation has been demonstrated, we know little
about how these two events are coupled. Using the 3D co-culture model of mammary epithelial cells and
monocytes, a recent study reveals a link between disruption of epithelial polarity and monocytes infiltration.
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The establishment and maintenance of epithelial polarity
is crucial for the integrity and function of mammary gland.
Loss of mammary tissue polarity is associated with cancer
development and progression [1, 2]. Disruption of the
polarized epithelial tissue structure occurs at the early stage
of breast cancer development. This event is associated with
the activation of PI3K-Rac1 signaling pathway and the
significant remodeling of tissue microenvironment.
Inhibition of the PI3K-Rac1 pathway reprograms the
non-polarized breast cancer cells to form polarized spheroids
in a 3D culture model [3, 4]. Using the 3D culture assay, we
found that disruption of polarized acinar structure is
accompanied with increased production of reactive oxygen
species (ROS) [5] (Figure 1A). ROS such as hydrogen
peroxide, superoxide and the hydroxyl radical, are
byproducts of normal metabolism through the electron
transport chain. ROS and associated oxidative stress drive
cancer development and progression by inducing oxidative

damages in DNA, lipids, proteins and other cellular
components [6, 7], but its function and regulation in the
disruption of tissue polarity has not been determined.
Treatment with antioxidant agents can reduce ROS levels
and reprogram non-polarized breast cancer cells to form
polarized spheroids in 3D culture, indicating that elevation of
ROS is necessary to disrupt polarized acinar formation. We
also found that introduction of a constitutively activated
RAC1 is sufficient to induce ROS generation in mammary
epithelial cells [5]. Activated RAC1 binds to and forms a
complex with NOX1, a homolog of the phagocyte
NADPH-oxidase component gp91phox. NOX1 has the
capacity to transport electrons across the plasma membrane
and to generate superoxide and other downstream ROS.
Therefore, RAC1 may increase NOX1-dependent ROS
generation. These results suggest that RAC1 is a potential
regulator that integrates non-polarized tissue formation and
ROS production (Figure 1B).
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Figure 1. (A) A scheme showing the association of epithelial polarity and ROS
production. (B) Summary overview of the signaling pathway in non-polarized breast cancer
cells that induces macrophage infiltration.

Macrophages comprise a major stromal component in the
tumor microenvironment. The infiltration and differentiation
of macrophages determine inflammation in malignant tissue,
which in turn promote breast cancer development and
progression [8, 9]. Infiltration of tumor-associated
macrophages correlates with poor prognosis in breast cancer
patients [10, 11]. Macrophage infiltration occurs at an early
stage of breast cancer development [12, 13]; therefore,
inhibition of early-stage events such as macrophage
infiltration and chronic inflammation may offer a promising
strategy to prevent or repress cancer progression. However, it
remains a challenge to block cancer-associated macrophage
infiltration without disturbing normal function of immune
system. Using the 3D co-culture model developed in our
group, we show that disruption of mammary tissue polarity
leads to monocyte/macrophage infiltration during cancer
development [5]. In addition, it has been reported that
macrophages accumulate around the terminal end buds of
mammary glands rather than near the polarized ductal
epithelial cells [14, 15]. Mammary epithelial cells in the
terminal end bud are multilayer and non-polarized. These
results also suggest that macrophage infiltration is associated
with loss of tissue polarity. Interestingly, reducing ROS
levels in non-polarized mammary epithelial cells is sufficient

to block THP-1 infiltration in 3D culture, indicating that
ROS are important mediators of the cancer cell-monocyte
interaction (Figure 1B). We show that ROS induce
expression of multiple cytokine genes in non-polarized
malignant cells [5]. These cytokines may promote recruitment
and infiltration of monocytes/macrophages in 3D culture.
The NF-κB pathway is a critical regulator of cytokine
expression and macrophage infiltration [16]. The gene
expression profile analysis and unbiased position weight
matrices analysis (PWMA) [17] show that the NF-kB pathway
is activated in non-polarized mammary epithelial cells [18].
ROS is a well-characterized regulator of the NF-κB pathway.
These results suggest the ROS may modulate
monocyte/macrophage infiltration by inducing the NF-κB
pathway in mammary epithelial cells (Figure 1B). However,
how aberrant activation of the NF-κB pathway in mammary
epithelial cells induces macrophage infiltration still remains
to be addressed.
Given the crucial role of ROS in regulating epithelial cell
polarity and macrophage infiltration, reducing ROS levels in
mammary epithelial cells may be a promising strategy to
inhibit cancer-associate inflammation and prevent cancer
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development and progression.
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